AsOf

Recorded or changed on this day 2026-11-08

44,851–44,900 of 46,535 claims, by entity. Everything on 2026-11-08 →

superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly net income · -57,165,000 United States dollar
Vertex Pharmaceuticals quarterly net income: -57,165,000 United States dollar, claim clm_2152B7E19DEE · ended · superseded by clm_E100CA9B87CC · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 2,946,703,000 United States dollar
Vertex Pharmaceuticals total assets: 2,946,703,000 United States dollar, claim clm_218F213EBD5A · ended · superseded by clm_E2CB6E1CCE2A · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly operating income · 3,353,000 United States dollar
Vertex Pharmaceuticals quarterly operating income: 3,353,000 United States dollar, claim clm_2228EE6A3A62 · ended · superseded by clm_FD2D956B4646 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · operating income · 2,856,290,000 United States dollar
Vertex Pharmaceuticals operating income: 2,856,290,000 United States dollar, claim clm_227207794AE5 · ended · superseded by clm_DB3896AB26E8 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly operating income · -142,203,000 United States dollar
Vertex Pharmaceuticals quarterly operating income: -142,203,000 United States dollar, claim clm_230B3E2BC570 · ended · superseded by clm_3ADC1054C2B6 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly net income · 762,100,000 United States dollar
Vertex Pharmaceuticals quarterly net income: 762,100,000 United States dollar, claim clm_243DDF043D62 · ended · superseded by clm_203BAAA42E77 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly research and development · 222,455,000 United States dollar
Vertex Pharmaceuticals quarterly research and development: 222,455,000 United States…, claim clm_246A631757AE · ended · superseded by clm_4D0F0C1EE546 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 14,432,300,000 United States dollar
Vertex Pharmaceuticals total equity: 14,432,300,000 United States dollar, claim clm_259DCABF6218 · ended · superseded by clm_B62228AD3B5C · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · net income · -642,178,000 United States dollar
Vertex Pharmaceuticals net income: -642,178,000 United States dollar, claim clm_25D63D0ED4EF · ended · superseded by clm_6694DF685051 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly revenue · 2,483,500,000 United States dollar
Vertex Pharmaceuticals quarterly revenue: 2,483,500,000 United States dollar, claim clm_25F0B0F08F89 · ended · superseded by clm_40945582F02C · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 1,356,405,000 United States dollar
Vertex Pharmaceuticals total equity: 1,356,405,000 United States dollar, claim clm_260A5D665F9C · ended · superseded by clm_9AE7AF8EC0D1 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly revenue · 166,076,000 United States dollar
Vertex Pharmaceuticals quarterly revenue: 166,076,000 United States dollar, claim clm_26173C591341 · ended · superseded by clm_86562BC405C6 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 26,484,400,000 United States dollar
Vertex Pharmaceuticals total assets: 26,484,400,000 United States dollar, claim clm_263F86EB65D1 · ended · superseded by clm_0B039E70EB86 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 1,021,546,000 United States dollar
Vertex Pharmaceuticals total equity: 1,021,546,000 United States dollar, claim clm_26C5F13E4AFA · ended · superseded by clm_A595BC2C5630 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly operating income · 1,040,900,000 United States dollar
Vertex Pharmaceuticals quarterly operating income: 1,040,900,000 United States dollar, claim clm_2A24B9B7FC69 · ended · superseded by clm_5B1D0BBCD832 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 999,180,000 United States dollar
Vertex Pharmaceuticals total equity: 999,180,000 United States dollar, claim clm_2A4FE21B733E · ended · superseded by clm_066255CCD67E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly research and development · 215,599,000 United States dollar
Vertex Pharmaceuticals quarterly research and development: 215,599,000 United States…, claim clm_2A57AC8A186B · ended · superseded by clm_03E4A3140826 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 2,392,234,000 United States dollar
Vertex Pharmaceuticals total assets: 2,392,234,000 United States dollar, claim clm_2B5B93D6737A · ended · superseded by clm_13FE3C35A2BF · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · net income · -112,052,000 United States dollar
Vertex Pharmaceuticals net income: -112,052,000 United States dollar, claim clm_2BC71558F3C9 · ended · superseded by clm_EAA313C25D3D · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 16,706,400,000 United States dollar
Vertex Pharmaceuticals total assets: 16,706,400,000 United States dollar, claim clm_2C70611C367D · ended · superseded by clm_9F22DDDCD1C9 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly operating income · 630,100,000 United States dollar
Vertex Pharmaceuticals quarterly operating income: 630,100,000 United States dollar, claim clm_2C985FE30E22 · ended · superseded by clm_E417E8C56F51 · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.
Vertex Pharmaceuticals · incorporated in · MA
Vertex Pharmaceuticals incorporated in: MA, claim clm_2D9EFA2C2469 · valid · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 255,656,889 shares
Vertex Pharmaceuticals shares outstanding: 255,656,889 shares, claim clm_2DB9804ECA5E · ended · superseded by clm_9180A1508E64 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly net income · 221,110,000 United States dollar
Vertex Pharmaceuticals quarterly net income: 221,110,000 United States dollar, claim clm_2E31B54439BF · ended · superseded by clm_C0D5B06E732F · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 6,085,200,000 United States dollar
Vertex Pharmaceuticals total equity: 6,085,200,000 United States dollar, claim clm_2E4E3E5F618D · ended · superseded by clm_C1525E494CB5 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 258,102,203 shares
Vertex Pharmaceuticals shares outstanding: 258,102,203 shares, claim clm_2E5075D7DBE3 · ended · superseded by clm_CDAE1063FD1E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 408,949,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 408,949,000 United States dollar, claim clm_2E63C80C1EC9 · ended · superseded by clm_F77D600A24ED · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 8,702,200,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 8,702,200,000 United States dollar, claim clm_2EBAE376F4A3 · ended · superseded by clm_0BD6127815F8 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 1,791,077,000 United States dollar
Vertex Pharmaceuticals total equity: 1,791,077,000 United States dollar, claim clm_2F530EB00B1B · ended · superseded by clm_A0081165ACC0 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · research and development · 855,506,000 United States dollar
Vertex Pharmaceuticals research and development: 855,506,000 United States dollar, claim clm_2F6A721A75E3 · ended · superseded by clm_09536F600AFF · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 4,939,600,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 4,939,600,000 United States dollar, claim clm_2FB43E38D7CC · ended · superseded by clm_B4475729CD2A · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly net income · 1,082,900,000 United States dollar
Vertex Pharmaceuticals quarterly net income: 1,082,900,000 United States dollar, claim clm_2FE795B3AF8B · ended · superseded by clm_58ABF4712193 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 256,789,869 shares
Vertex Pharmaceuticals shares outstanding: 256,789,869 shares, claim clm_30424A529FF7 · ended · superseded by clm_7659E4652BD8 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · revenue · 1,702,177,000 United States dollar
Vertex Pharmaceuticals revenue: 1,702,177,000 United States dollar, claim clm_3048F4177FBD · ended · superseded by clm_88AABB0F5900 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 4,335,386,000 United States dollar
Vertex Pharmaceuticals total assets: 4,335,386,000 United States dollar, claim clm_30C87D2C1CBD · ended · superseded by clm_C2CDDE4D143F · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · operating income · 635,150,000 United States dollar
Vertex Pharmaceuticals operating income: 635,150,000 United States dollar, claim clm_30D3676BC4AE · ended · superseded by clm_05A793B89218 · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.
Vertex Pharmaceuticals · quarterly revenue · 3,440,800,000 United States dollar
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 10,907,000,000 United States dollar
Vertex Pharmaceuticals total equity: 10,907,000,000 United States dollar, claim clm_318FD2D6E763 · ended · superseded by clm_53E6658C91B5 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly operating income · -134,065,000 United States dollar
Vertex Pharmaceuticals quarterly operating income: -134,065,000 United States dollar, claim clm_31AFB2309D37 · ended · superseded by clm_4AA01F0AE5BB · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 18,665,800,000 United States dollar
Vertex Pharmaceuticals total equity: 18,665,800,000 United States dollar, claim clm_335F6E7CE9CE · ended · superseded by clm_0F975664C00F · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · operating income · -232,900,000 United States dollar
Vertex Pharmaceuticals operating income: -232,900,000 United States dollar, claim clm_33A4466539E6 · ended · superseded by clm_08B6F6FEE28A · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly net income · 1,099,600,000 United States dollar
Vertex Pharmaceuticals quarterly net income: 1,099,600,000 United States dollar, claim clm_33B55A456707 · ended · superseded by clm_B131D7103BCE · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 976,458,000 United States dollar
Vertex Pharmaceuticals total equity: 976,458,000 United States dollar, claim clm_33DE4ADFA95C · ended · superseded by clm_12232D5A6B98 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly net income · 128,746,000 United States dollar
Vertex Pharmaceuticals quarterly net income: 128,746,000 United States dollar, claim clm_346AA350FC6D · ended · superseded by clm_BFDA13517B9A · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 2,334,679,000 United States dollar
Vertex Pharmaceuticals total assets: 2,334,679,000 United States dollar, claim clm_34CC74560F05 · ended · superseded by clm_D21E1EE854F6 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly net income · -159,382,000 United States dollar
Vertex Pharmaceuticals quarterly net income: -159,382,000 United States dollar, claim clm_34EE023B80C3 · ended · superseded by clm_F0EB4C4B4423 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly net income · -308,016,000 United States dollar
Vertex Pharmaceuticals quarterly net income: -308,016,000 United States dollar, claim clm_34EFC0C950B9 · ended · superseded by clm_2152B7E19DEE · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 20,349,200,000 United States dollar
Vertex Pharmaceuticals total assets: 20,349,200,000 United States dollar, claim clm_351DD5011D1D · ended · superseded by clm_9193F0BF1A10 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly research and development · 158,612,000 United States dollar
Vertex Pharmaceuticals quarterly research and development: 158,612,000 United States…, claim clm_35956A6601A7 · ended · superseded by clm_B5FD1F0507D0 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 5,492,900,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 5,492,900,000 United States dollar, claim clm_379D75861ABB · ended · superseded by clm_0DE5C5FBB098 · 1 source (1 primary) · conf 0.95

What the statuses mean